Liver regeneration: From laboratory to clinic

Liver Transplantation

Volumn 7, Issue 10, 2001, Pages 835-844

  Fausto, Nelson ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CYTOKINE; EPIDERMAL GROWTH FACTOR; GLUCOSE; GROWTH FACTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; KERATINOCYTE GROWTH FACTOR; SCATTER FACTOR; STAT PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; BODY WEIGHT; CELL DIVISION; CELL PROLIFERATION; CLINICAL OBSERVATION; CLINICAL PRACTICE; CONTROLLED STUDY; DNA REPLICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LABORATORY; LIVER CELL; LIVER LOBECTOMY; LIVER NECROSIS; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVER WEIGHT; LIVING DONOR; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVIEW; STEM CELL; SURGICAL MORTALITY;

EID: 0034766724     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1053/jlts.2001.27865     Document Type: Article

References (95)

1. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal
2. Liver regeneration
3. Initiation of liver regeneration by tumor necrosis factor
4. Liver regeneration
5. Liver regeneration following partial hepatectomy: Genes and metabolism
6. Dynamics of normal and injured human liver regeneration after partial hepatectomy as assessed on the basis of computed tomography and liver function
7. Liver regeneration in recipients and donors after transplantation
8. Living related liver transplantation in adults
9. Liver regeneration and function in donor and recipient after right lobe adult to adult living donor liver transplantation
10. Adult-to-adult living-related liver transplantation using the right lobe
11. Patterns of restoration of remnant liver volume after graft harvesting in donors for living related liver transplantation
12. Hepatic regeneration
13. Regeneration of mammalian liver
14. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised
15. Cellular proliferation in the liver
16. Responses to the liver injury
17. Regeneration of liver parenchyma under normal and pathological conditions
18. Cell cycle and liver function
19. Mitotic activity in the liver of the mouse during inanition followed by refeeding with different levels of protein
20. Induction of replicative competence ("priming") in normal liver
21. Appearance of nyctohemeral rhythm of mitosis in the very young rat
22. Relation between the circadian rhythms of mitotic rate and cholesterol-7-hydroxylase activity in the regenerating liver
23. Accelerated response of hepatic DNA synthesis to partial hepatectomy in rats pretreated with growth hormone or surgical stress
24. 3
25. The liver
26. Timing of hepatocyte entry into DNA synthesis after partial hepatectomy is cell autonomous
27. Adult-to-adult living-donor liver transplantation: A critical analysis
28. Adult living donor liver transplantation: The hepatologist's perspective
29. Small-for-size liver transplanted into larger recipient: A model of hepatic regeneration
30. Evidence that host size determines liver size: Studies in dogs receiving orthotopic liver transplants
31. Replacement of diseased mouse liver by hepatic cell transplantation
32. Complete reconstitution of mouse liver with xenogeneic hepatocytes
33. The repopulation potential of hepatocyte populations differing in size and prior mitotic expansion
34. Hepatocyte transplantation into diseased mouse liver. Kinetics of parenchymal repopulation and identification of the proliferative capacity of tetraploid and octaploid hepatocytes
35. Liver regeneration
36. Hepatocyte differentiation and liver progenitor cells
37. Activation proliferation and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration
38. Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse
39. Long-term, near-total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine
40. Cell lineages in human liver development, regeneration and transformation
41. Rat liver stem cells: Prospects for the future
42. The canals of Hering and hepatic stem cells in humans
43. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo
44. Bone marrow as a potential source of hepatic oval cells
45. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration
46. Transcriptional control of liver regeneration
47. Regulation of signal transduction during liver regeneration
48. In vivo response of hepatocytes to growth factors requires an initial priming stimulus
49. Tumor necrosis factor primes hepatocytes for DNA replication in the rat
50. Collagenase pretreatment and the mitogenic effects of hepatocyte growth factor and transforming growth factor-α in adult rat liver
51. Hepatocyte growth factor induces hepatocyte proliferation in vivo and allows for efficient retroviral-mediated gene transfer in mice
52. Serum transforming growth factor-alpha level can be a parameter for evaluating liver regeneration after partial hepatectomy in patients with liver cancer
53. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay
54. Serum hepatocyte growth factor levels in hepatectomized and nonhepatectomized surgical patients
55. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay
56. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy
57. Acute-phase response factor, increased binding, and target gene transcription during liver regeneration
58. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: Requirement for type 1 but not type 2 receptor
59. Induction patterns of 70 genes during nine days after hepatectomy define the temporal course of liver regeneration. J.
60. Rapid induction in regenerating liver of RL/IF-1 (an IκB that inhibits NF-κB, RelB-p50, and c-Rel-p50) and PHF, a novel κB site-binding complex
61. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration
62. Rapid activation of the STAT3 transcription complex in liver regeneration
63. Regenerative changes in C/EBPαC/EBPβ expression modulate binding to the C/EBP site in the c-fos promoter
64. 1 phase of the hepatocyte cell cycle
65. CCAAT enhancer-binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy
66. Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lacking type I tumor necrosis factor receptor
67. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice
68. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice
69. NF-kappaB prevents apoptosis and liver dysfunction during liver regeneration
70. Restriction of gut-derived endotoxin impairs DNA synthesis for liver regeneration
71. Depressed liver regeneration after partial hepatectomy of germ free, athymic and lipopolysaccharide-resistant mice
72. Impaired liver regeneration in inducible nitric oxide synthase-deficient mice
73. Cytokine regulation of liver injury and repair
74. Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases
75. Regulation of G(1) cyclin-dependent kinases in the liver: Role of nuclear localization and p27 sequestration
76. 1
77. The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes
78. Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes
79. Liver regeneration versus direct hyperplasia
80. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration
81. Hepatocyte growth factor
82. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism
83. Hepatocyte growth factor in liver growth and differentiation
84. Modifications of the hepatocyte growth factor/c-met pathway by constitutive expression of transforming growth factor-alpha in rat liver epithelial cells
85. TGFα expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between TGFα and HGF
86. The mitogenic activity of hepatocyte growth factor on rat hepatocytes is dependent upon endogenous transforming growth factor-alpha
87. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract
88. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy
89. Possible roles of nonparenchymal cells in hepatocyte proliferation induced by lead nitrate and by tumor necrosis factor alpha
90. Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy
91. Disruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line
92. Oxidative stress: Role of mitochondria and protection by glutathione
93. Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of IL-6
94. Hepatocellular oxidative stress and initial graft injury in human liver transplantation
95. Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2